Jagar Jasem

457 total citations
16 papers, 324 citations indexed

About

Jagar Jasem is a scholar working on Pathology and Forensic Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jagar Jasem has authored 16 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jagar Jasem's work include Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Jagar Jasem is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Jagar Jasem collaborates with scholars based in United States, Iraq and Vietnam. Jagar Jasem's co-authors include Arya Amini, Virginia F. Borges, Christine M. Fisher, Anthony Elias, Peter Kabos, Rachel Rabinovitch, Daniel W. Bowles, Tyler P. Robin, David Raben and Bernard L. Jones and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Medicine.

In The Last Decade

Jagar Jasem

14 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jagar Jasem United States 9 77 72 67 61 56 16 324
Sarah S. Kılıç United States 9 68 0.9× 24 0.3× 96 1.4× 25 0.4× 116 2.1× 26 252
Pedro De Marchi Brazil 11 58 0.8× 115 1.6× 277 4.1× 57 0.9× 61 1.1× 57 514
Swee Peng Yap Singapore 11 84 1.1× 22 0.3× 187 2.8× 38 0.6× 96 1.7× 23 372
Manuel Molina United States 7 183 2.4× 67 0.9× 210 3.1× 26 0.4× 170 3.0× 8 448
Xiaofei Sun China 10 25 0.3× 19 0.3× 79 1.2× 22 0.4× 48 0.9× 68 262
Piotr Skotnicki Poland 12 15 0.2× 98 1.4× 135 2.0× 13 0.2× 80 1.4× 31 392
Lauren Cobb United States 10 13 0.2× 43 0.6× 150 2.2× 26 0.4× 89 1.6× 30 353
Bhavana V. Chapman United States 13 104 1.4× 39 0.5× 67 1.0× 5 0.1× 143 2.6× 26 400
Megan Eguchi United States 11 76 1.0× 66 0.9× 189 2.8× 26 0.4× 97 1.7× 37 402
S.L. Vowler United Kingdom 11 13 0.2× 36 0.5× 98 1.5× 19 0.3× 65 1.2× 12 328

Countries citing papers authored by Jagar Jasem

Since Specialization
Citations

This map shows the geographic impact of Jagar Jasem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jagar Jasem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jagar Jasem more than expected).

Fields of papers citing papers by Jagar Jasem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jagar Jasem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jagar Jasem. The network helps show where Jagar Jasem may publish in the future.

Co-authorship network of co-authors of Jagar Jasem

This figure shows the co-authorship network connecting the top 25 collaborators of Jagar Jasem. A scholar is included among the top collaborators of Jagar Jasem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jagar Jasem. Jagar Jasem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Allen, Jessica, Diana Abbott, Steven M. Bair, et al.. (2024). DA-R-EPOCH May Mitigate the Adverse Prognostic Implication of the Diagnosis-to-Treatment Interval (DTI) in Large B-Cell Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 25(1). e26–e33.
2.
Colton, Meryl D., Enkhtsetseg Purev, Bradley M. Haverkos, et al.. (2024). Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy. Clinical Lymphoma Myeloma & Leukemia. 24(11). 778–782. 1 indexed citations
3.
Haverkos, Bradley M., Jasmine M. Zain, Manali Kamdar, et al.. (2023). Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial. Blood Advances. 8(3). 708–711. 2 indexed citations
4.
Bradley, Cathy J., et al.. (2022). Cancer Treatment Data in Central Cancer Registries: When Are Supplemental Data Needed?. Cancer Informatics. 21. 2663739017–2663739017. 11 indexed citations
5.
Haverkos, Bradley M., Jasmine Zain, Manali Kamdar, et al.. (2022). Results from a Phase I Trial Using Nivolumab in Combination with Dose Adjusted EPOCH in Newly Diagnosed Peripheral T-Cell Lymphomas. Blood. 140(Supplement 1). 2308–2309.
6.
Zain, Jasmine, Manali Kamdar, Alexander Neuwelt, et al.. (2021). A Pilot Study Using Nivolumab in Combination with Standard of Care Chemotherapy in Newly Diagnosed Peripheral T-Cell Lymphomas. Blood. 138(Supplement 1). 2444–2444. 2 indexed citations
7.
Bahouth, Mona N., Peggy S. Kraus, Kathryn Dane, et al.. (2019). Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides. Medicine. 98(36). e17015–e17015. 4 indexed citations
8.
Vaught, Arthur J., Evan M. Braunstein, Jagar Jasem, et al.. (2018). Germline mutations in the alternative pathway of complement predispose to HELLP syndrome. JCI Insight. 3(6). 70 indexed citations
9.
Mohammad, Ameen Mosa, et al.. (2018). Vitamin D status in acute myocardial infarction: a case–control study. PubMed. 7(4). 93–96. 6 indexed citations
10.
Jasem, Jagar, Christine M. Fisher, Arya Amini, et al.. (2017). The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?. Journal of the National Comprehensive Cancer Network. 15(4). 494–503. 37 indexed citations
11.
Amini, Arya, Jagar Jasem, Bernard L. Jones, et al.. (2016). Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Oral Oncology. 56. 1–7. 78 indexed citations
12.
Jasem, Jagar, Arya Amini, Rachel Rabinovitch, et al.. (2016). 21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile. Journal of Clinical Oncology. 34(17). 1995–2002. 40 indexed citations
13.
Bhatt, Vijaya Raj, Jagar Jasem, Smith Giri, et al.. (2015). Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 15(10). 606–611. 20 indexed citations
14.
Jasem, Jagar, et al.. (2014). An epidemiological analysis of acute flaccid paralysis and its surveillance system in Iraq, 1997-2011. BMC Infectious Diseases. 14(1). 448–448. 14 indexed citations
15.
Jasem, Jagar, et al.. (2013). Guillain-Barré syndrome as a cause of acute flaccid paralysis in Iraqi children: a result of 15 years of nation-wide study. BMC Neurology. 13(1). 195–195. 18 indexed citations
16.
Jasem, Jagar, et al.. (2011). Epidemiological analysis of measles and evaluation of measles surveillance system performance in Iraq, 2005–2010. International Journal of Infectious Diseases. 16(3). e166–e171. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah S. Kılıç Breakdown of academic impact, for papers by Pedro De Marchi Breakdown of academic impact, for papers by Swee Peng Yap Breakdown of academic impact, for papers by Manuel Molina Breakdown of academic impact, for papers by Xiaofei Sun Breakdown of academic impact, for papers by Piotr Skotnicki Breakdown of academic impact, for papers by Lauren Cobb Breakdown of academic impact, for papers by Bhavana V. Chapman Breakdown of academic impact, for papers by Megan Eguchi Breakdown of academic impact, for papers by S.L. Vowler
Rankless by CCL
2026